ANXA5 and acute myeloid leukemia: Silencing NONO was found to increase the sensitivity of acute myelogenous leukemia (AML) cells to cytarabine (Ara-C), as demonstrated by cell proliferation and Annexin V apoptosis assays (Zhang et al., 2022a).